SonoScape Medical Corp.

Shenzhen Stock Exchange 300633.SZ

SonoScape Medical Corp. Capital Expenditure for the year ending December 31, 2023: USD -24.93 M

SonoScape Medical Corp. Capital Expenditure is USD -24.93 M for the year ending December 31, 2023, a 9.61% change year over year. Capital expenditure is cash spent on acquiring or maintaining fixed assets, such as property, plants, and equipment (PP&E).

SonoScape Medical Corp. Capital Expenditure for the year ending December 31, 2022 was USD -27.58 M, a -15.11% change year over year.
SonoScape Medical Corp. Capital Expenditure for the year ending December 31, 2021 was USD -23.96 M, a -0.71% change year over year.
SonoScape Medical Corp. Capital Expenditure for the year ending December 31, 2020 was USD -23.79 M, a -4.33% change year over year.
SonoScape Medical Corp. Capital Expenditure for the year ending December 31, 2019 was USD -22.80 M, a -93.90% change year over year.

Key data

Date	Capital Expenditure	Free Cash Flow	Depreciation And Amortization	Deferred Income Tax

Shenzhen Stock Exchange: 300633.SZ

SonoScape Medical Corp.

CEO	Mr. Kunxiang Wu
IPO Date	April 7, 2017
Location	China
Headquarters	Shenzhen Software Park, 12
Employees	2,697
Sector	Healthcare
Industries Medical Instruments 3D Printing Biotechnology Defense & Military Hardware & Electronics Plastics Robotics

Description

SonoScape Medical Corp. develops and manufactures medical equipment in China and internationally. The company offers ultrasound diagnostic systems, such as trolley color Doppler, portable color Doppler, B/W ultrasound, and veterinary ultrasound equipment; and endoscopy equipment, such as image processors, light sources, and gastroenterology products. It also provides technical and spare parts support, training, upgradation, and field services. SonoScape Medical Corp. was founded in 2002 and is based in Shenzhen, China.

Key trends

Past 5 years